BIA response to Isomorphic £3.8 billion raise
Chris Molloy, CEO of the BioIndustry Association (BIA), said:
“Isomorphic Labs’ £3.8 billion ($5 billion) investment is not only a new peak for UK-founded companies; it is the largest ever venture capital raise for life sciences globally. This is a powerful vote of confidence in UK life sciences and a strong endorsement for our TechBio sector. Bringing breakthrough AI and drug discovery together offers extraordinary potential to tackle diseases that still lack effective treatments.
“When companies with exceptional science receive exceptional backing, it enables them to grow, scale and serve the world from here. Britain can be a place where it is common for scientific breakthroughs to become global businesses and, ultimately, life-changing medicines.”